test

Fan Yu

@Ally Bridge Group (ny) Llc

Latest period2024 - Q3ReportedManaged Assets$186.813MTotal holdings29
Assets growth rate11.3%Assets growth rate (2-Q avg)2.31%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ally Bridge Group (ny) Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Ally Bridge Group (ny) Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 186.813M in assets, with a quarterly growth rate of 11.3% and a 2-quarter average growth rate of 2.31%. The portfolio is managed by Fan Yu, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
INSMInsmed Inc
Recent Activity
Increased 16.93%
5.9%
$11.011M
150,833 shares@ $73.0 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
New Position
5.67%
$10.587M
321,898 shares@ $32.89 avg price
MRUSMerus N V
Recent Activity
Increased 19.11%
5.57%
$10.404M
208,244 shares@ $49.96 avg price
CGONCg Oncology Inc
Recent Activity
Increased 50.55%
5.32%
$9.933M
263,266 shares@ $37.73 avg price
BPMCBlueprint Medicines Corp
Recent Activity
Increased 40.25%
5.26%
$9.812M
106,080 shares@ $92.5 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Decreased -2.04%
4.82%
$8.992M
72,000 shares@ $124.89 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 25.05%
4.47%
$8.338M
211,791 shares@ $39.38 avg price
LBPHLongboard Pharmaceuticals In
Recent Activity
Increased 10.01%
4.3%
$8.029M
240,892 shares@ $33.33 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Increased 82.73%
4.03%
$7.514M
399,466 shares@ $18.81 avg price
RVMDRevolution Medicines Inc
Recent Activity
New Position
3.97%
$7.415M
163,500 shares@ $45.35 avg price